Xin. Rong, et.al., Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion., eLife, 2015, 4

http://rdf.ncbi.nlm.nih.gov/pubmed/25806685

Xin. Rong, et.al., Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion., eLife, 2015, 4

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Lpcat3<tm1c(EUCOMM)Wtsi>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5822780

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• abnormal lipid homeostasis_Lpcat3<tm1c(EUCOMM)Wtsi>/Lpcat3<tm1c(EUCOMM)Wtsi>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0002118IC57BL6C57BL6NSJLLpcat3tm1cEUCOMMWtsiLpcat3tm1cEUCOMMWtsiTgAlbcre21Mgn0TgAlbcre21MgnLpcat3tm1cEUCOMMWtsi
• hepatic steatosis_Lpcat3<tm1c(EUCOMM)Wtsi>/Lpcat3<tm1c(EUCOMM)Wtsi>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0002628IC57BL6C57BL6NSJLLpcat3tm1cEUCOMMWtsiLpcat3tm1cEUCOMMWtsiTgAlbcre21Mgn0TgAlbcre21MgnLpcat3tm1cEUCOMMWtsi
• increased liver cholesterol level_Lpcat3<tm1c(EUCOMM)Wtsi>/Lpcat3<tm1c(EUCOMM)Wtsi>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0010027IC57BL6C57BL6NSJLLpcat3tm1cEUCOMMWtsiLpcat3tm1cEUCOMMWtsiTgAlbcre21Mgn0TgAlbcre21MgnLpcat3tm1cEUCOMMWtsi
• decreased circulating VLDL triglyceride level_Lpcat3<tm1c(EUCOMM)Wtsi>/Lpcat3<tm1c(EUCOMM)Wtsi>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0003976IC57BL6C57BL6NSJLLpcat3tm1cEUCOMMWtsiLpcat3tm1cEUCOMMWtsiTgAlbcre21Mgn0TgAlbcre21MgnLpcat3tm1cEUCOMMWtsi
• abnormal lipid level_Lpcat3<tm1c(EUCOMM)Wtsi>/Lpcat3<tm1c(EUCOMM)Wtsi>,Tg(Vil1-cre)997Gum/0
  http://metadb.riken.jp/0001547IC57BL6C57BL6NSJLLpcat3tm1cEUCOMMWtsiLpcat3tm1cEUCOMMWtsiTgVil1cre997Gum0Lpcat3tm1cEUCOMMWtsiTgVil1cre997Gum
• decreased circulating glucose level_Lpcat3<tm1c(EUCOMM)Wtsi>/Lpcat3<tm1c(EUCOMM)Wtsi>,Tg(Vil1-cre)997Gum/0
  http://metadb.riken.jp/0005560IC57BL6C57BL6NSJLLpcat3tm1cEUCOMMWtsiLpcat3tm1cEUCOMMWtsiTgVil1cre997Gum0Lpcat3tm1cEUCOMMWtsiTgVil1cre997Gum
• increased liver triglyceride level_Lpcat3<tm1c(EUCOMM)Wtsi>/Lpcat3<tm1c(EUCOMM)Wtsi>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0009355IC57BL6C57BL6NSJLLpcat3tm1cEUCOMMWtsiLpcat3tm1cEUCOMMWtsiTgAlbcre21Mgn0TgAlbcre21MgnLpcat3tm1cEUCOMMWtsi
• decreased circulating triglyceride level_Lpcat3<tm1c(EUCOMM)Wtsi>/Lpcat3<tm1c(EUCOMM)Wtsi>,Tg(Vil1-cre)997Gum/0
  http://metadb.riken.jp/0002644IC57BL6C57BL6NSJLLpcat3tm1cEUCOMMWtsiLpcat3tm1cEUCOMMWtsiTgVil1cre997Gum0Lpcat3tm1cEUCOMMWtsiTgVil1cre997Gum
• decreased body weight_Lpcat3<tm1c(EUCOMM)Wtsi>/Lpcat3<tm1c(EUCOMM)Wtsi>,Tg(Vil1-cre)997Gum/0
  http://metadb.riken.jp/0001262IC57BL6C57BL6NSJLLpcat3tm1cEUCOMMWtsiLpcat3tm1cEUCOMMWtsiTgVil1cre997Gum0Lpcat3tm1cEUCOMMWtsiTgVil1cre997Gum
• decreased circulating insulin level_Lpcat3<tm1c(EUCOMM)Wtsi>/Lpcat3<tm1c(EUCOMM)Wtsi>,Tg(Vil1-cre)997Gum/0
  http://metadb.riken.jp/0002727IC57BL6C57BL6NSJLLpcat3tm1cEUCOMMWtsiLpcat3tm1cEUCOMMWtsiTgVil1cre997Gum0Lpcat3tm1cEUCOMMWtsiTgVil1cre997Gum
• abnormal phospholipid level_Lpcat3<tm1c(EUCOMM)Wtsi>/Lpcat3<tm1c(EUCOMM)Wtsi>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0004777IC57BL6C57BL6NSJLLpcat3tm1cEUCOMMWtsiLpcat3tm1cEUCOMMWtsiTgAlbcre21Mgn0TgAlbcre21MgnLpcat3tm1cEUCOMMWtsi
• postnatal lethality, complete penetrance_Lpcat3<tm1a(EUCOMM)Wtsi>/Lpcat3<tm1a(EUCOMM)Wtsi>
  http://metadb.riken.jp/0011085IC57BL6NLpcat3tm1aEUCOMMWtsiLpcat3tm1aEUCOMMWtsiLpcat3tm1aEUCOMMWtsi
• abnormal lipid metabolism_Lpcat3<tm1a(EUCOMM)Wtsi>/Lpcat3<tm1a(EUCOMM)Wtsi>
  http://metadb.riken.jp/0013245IC57BL6NLpcat3tm1aEUCOMMWtsiLpcat3tm1aEUCOMMWtsiLpcat3tm1aEUCOMMWtsi
• decreased circulating glucose level_Lpcat3<tm1a(EUCOMM)Wtsi>/Lpcat3<tm1a(EUCOMM)Wtsi>
  http://metadb.riken.jp/0005560IC57BL6NLpcat3tm1aEUCOMMWtsiLpcat3tm1aEUCOMMWtsiLpcat3tm1aEUCOMMWtsi
• decreased circulating triglyceride level_Lpcat3<tm1c(EUCOMM)Wtsi>/Lpcat3<tm1c(EUCOMM)Wtsi>
  http://metadb.riken.jp/0002644IC57BL6C57BL6NSJLLpcat3tm1cEUCOMMWtsiLpcat3tm1cEUCOMMWtsiLpcat3tm1cEUCOMMWtsi
• abnormal lipid level_Lpcat3<tm1c(EUCOMM)Wtsi>/Lpcat3<tm1c(EUCOMM)Wtsi>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0001547IC57BL6C57BL6NSJLLpcat3tm1cEUCOMMWtsiLpcat3tm1cEUCOMMWtsiTgAlbcre21Mgn0TgAlbcre21MgnLpcat3tm1cEUCOMMWtsi
• decreased circulating triglyceride level_Lpcat3<tm1c(EUCOMM)Wtsi>/Lpcat3<tm1c(EUCOMM)Wtsi>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0002644IC57BL6C57BL6NSJLLpcat3tm1cEUCOMMWtsiLpcat3tm1cEUCOMMWtsiTgAlbcre21Mgn0TgAlbcre21MgnLpcat3tm1cEUCOMMWtsi
• abnormal circulating apolipoprotein level_Lpcat3<tm1c(EUCOMM)Wtsi>/Lpcat3<tm1c(EUCOMM)Wtsi>,Tg(Alb-cre)21Mgn/0
  http://metadb.riken.jp/0010332IC57BL6C57BL6NSJLLpcat3tm1cEUCOMMWtsiLpcat3tm1cEUCOMMWtsiTgAlbcre21Mgn0TgAlbcre21MgnLpcat3tm1cEUCOMMWtsi
• abnormal enterocyte morphology_Lpcat3<tm1c(EUCOMM)Wtsi>/Lpcat3<tm1c(EUCOMM)Wtsi>,Tg(Vil1-cre)997Gum/0
  http://metadb.riken.jp/0000479IC57BL6C57BL6NSJLLpcat3tm1cEUCOMMWtsiLpcat3tm1cEUCOMMWtsiTgVil1cre997Gum0Lpcat3tm1cEUCOMMWtsiTgVil1cre997Gum
• abnormal liver physiology_Lpcat3<tm1c(EUCOMM)Wtsi>/Lpcat3<tm1c(EUCOMM)Wtsi>
  http://metadb.riken.jp/0000609IC57BL6C57BL6NSJLLpcat3tm1cEUCOMMWtsiLpcat3tm1cEUCOMMWtsiLpcat3tm1cEUCOMMWtsi
• postnatal growth retardation_Lpcat3<tm1c(EUCOMM)Wtsi>/Lpcat3<tm1c(EUCOMM)Wtsi>,Tg(Vil1-cre)997Gum/0
  http://metadb.riken.jp/0001732IC57BL6C57BL6NSJLLpcat3tm1cEUCOMMWtsiLpcat3tm1cEUCOMMWtsiTgVil1cre997Gum0Lpcat3tm1cEUCOMMWtsiTgVil1cre997Gum

class

http://purl.org/net/cito/citesAsAuthority

• Lpcat3<tm1c(EUCOMM)Wtsi>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5822780